Nevakar spins off ophthalmic-only company Vyluma

Video

A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.

Navneet Puri, PhD, founder, chairman, and CEO of newly formed Vyluma discusses why Nevakar chose to make the move to ophthalmic-only pharma.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Karl Stonecipher ASCRS 2025
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Paul Karpecki, OD, FAAO
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Related Content
Child applying contact lens to eye Image credit: AdobeStock/zulfiska

New study supports retention of myopia control in CooperVision's MiSight 1 day contact lenses

Jordana Joy, Associate Editor
May 6th 2025
Article
You and Eye by Optometry Times with host Miriam Korik, OD

You and Eye: Myopia cannot be viewed as a specialty in today's practice setting

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 18th 2024
Podcast
Boy wearing DOT lenses with family in background Image credit: SightGlassVision

SightGlass Vision studies find DOT spectacle lenses as highly effective for myopia management, show no evidence of rebound

Jordana Joy, Associate Editor
May 2nd 2025
Article
You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 9th 2024
Podcast
Red light grid Image credit: AdobeStock/VictorMoussa

Changes in cone density after low-level red light treatment in children with myopia

Lynda Charters
April 25th 2025
Article
Atropine 0.05% receives CDSCO approval in India for myopia management. - Image credit:©vitalis83 – stock.adobe.com

ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops in India

Hattie Hayes;Emily Kaiser Maharjan, Assistant Managing Editor;Jordana Joy, Associate Editor
April 23rd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.